AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
6.74
+0.02 (0.30%)
Nov 20, 2024, 4:00 PM EST - Market closed
AngioDynamics Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2019 - 2015 |
Revenue | 292.73 | 303.91 | 338.75 | 316.22 | 291.01 | 264.16 | Upgrade
|
Revenue Growth (YoY) | -12.85% | -10.28% | 7.13% | 8.66% | 10.17% | -2.39% | Upgrade
|
Cost of Revenue | 141.36 | 149.22 | 164.51 | 150.49 | 134.22 | 113.89 | Upgrade
|
Gross Profit | 151.36 | 154.7 | 174.25 | 165.73 | 156.79 | 150.27 | Upgrade
|
Selling, General & Admin | 142.58 | 144.18 | 144.45 | 134.01 | 117.22 | 116.51 | Upgrade
|
Research & Development | 29.61 | 31.32 | 29.69 | 30.48 | 36.39 | 29.68 | Upgrade
|
Other Operating Expenses | 5.76 | 5.76 | - | - | - | - | Upgrade
|
Operating Expenses | 189.95 | 194.3 | 192.93 | 183.95 | 171.75 | 164.31 | Upgrade
|
Operating Income | -38.59 | -39.6 | -18.68 | -18.22 | -14.96 | -14.04 | Upgrade
|
Interest Expense | - | - | -2.7 | -0.69 | -0.86 | -0.91 | Upgrade
|
Interest & Investment Income | 2.1 | 1.61 | - | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -0.7 | -0.82 | -0.55 | -0.79 | 0.09 | -0.13 | Upgrade
|
EBT Excluding Unusual Items | -37.19 | -38.81 | -21.94 | -19.7 | -15.73 | -15.07 | Upgrade
|
Merger & Restructuring Charges | -15.37 | -12.37 | -1.46 | -0.7 | -0 | -0.78 | Upgrade
|
Impairment of Goodwill | -159.48 | -159.48 | -14.55 | - | - | -158.58 | Upgrade
|
Gain (Loss) on Sale of Assets | 6.66 | 54.5 | - | - | -0.39 | -2.81 | Upgrade
|
Asset Writedown | - | - | - | - | -13.95 | - | Upgrade
|
Legal Settlements | -33.63 | -34.94 | -10 | -7.63 | -6.16 | -2.67 | Upgrade
|
Other Unusual Items | -0.16 | -0.55 | -6.5 | -1.93 | 0.19 | 11.77 | Upgrade
|
Pretax Income | -239.16 | -191.64 | -54.44 | -29.95 | -36.05 | -168.14 | Upgrade
|
Income Tax Expense | 3.87 | -7.29 | -2 | -3.4 | -4.5 | -1.35 | Upgrade
|
Earnings From Continuing Operations | -243.03 | -184.35 | -52.44 | -26.55 | -31.55 | -166.79 | Upgrade
|
Net Income | -243.03 | -184.35 | -52.44 | -26.55 | -31.55 | -166.79 | Upgrade
|
Net Income to Common | -243.03 | -184.35 | -52.44 | -26.55 | -31.55 | -166.79 | Upgrade
|
Shares Outstanding (Basic) | 40 | 40 | 39 | 39 | 38 | 38 | Upgrade
|
Shares Outstanding (Diluted) | 40 | 40 | 39 | 39 | 38 | 38 | Upgrade
|
Shares Change (YoY) | 1.86% | 1.77% | 1.21% | 1.74% | 1.00% | 1.27% | Upgrade
|
EPS (Basic) | -6.02 | -4.59 | -1.33 | -0.68 | -0.82 | -4.39 | Upgrade
|
EPS (Diluted) | -6.02 | -4.59 | -1.33 | -0.68 | -0.82 | -4.39 | Upgrade
|
Free Cash Flow | -23.33 | -30.68 | -3.73 | -11.49 | 18.91 | -21.79 | Upgrade
|
Free Cash Flow Per Share | -0.58 | -0.76 | -0.09 | -0.29 | 0.49 | -0.57 | Upgrade
|
Gross Margin | 51.71% | 50.90% | 51.44% | 52.41% | 53.88% | 56.89% | Upgrade
|
Operating Margin | -13.18% | -13.03% | -5.51% | -5.76% | -5.14% | -5.31% | Upgrade
|
Profit Margin | -83.02% | -60.66% | -15.48% | -8.40% | -10.84% | -63.14% | Upgrade
|
Free Cash Flow Margin | -7.97% | -10.09% | -1.10% | -3.63% | 6.50% | -8.25% | Upgrade
|
EBITDA | -13.18 | -14.29 | 12.19 | 11.13 | 10.95 | 9.77 | Upgrade
|
EBITDA Margin | -4.50% | -4.70% | 3.60% | 3.52% | 3.76% | 3.70% | Upgrade
|
D&A For EBITDA | 25.41 | 25.31 | 30.87 | 29.35 | 25.92 | 23.81 | Upgrade
|
EBIT | -38.59 | -39.6 | -18.68 | -18.22 | -14.96 | -14.04 | Upgrade
|
EBIT Margin | -13.18% | -13.03% | -5.51% | -5.76% | -5.14% | -5.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.